Bial - Portela & CA S.A. et al v. SPH Shanghai Zhongxi Pharmaceutical Co., Ltd. > Summary
Court Case Number 1:18-cv-00775
Filing Date May 21, 2018
Termination Date May 27, 2020
Court Delaware District Court
Status Dismissed - Settled
Plaintiff Attorneys
28Bial
Attorney Name: Steven J. Balick
Ashby & Geddes
Bial
Attorney Name: Meredith H. Boerschlein
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial
Attorney Name: Charles T. Collins-Chase
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial
Attorney Name: Lauren J. Robinson
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Bial
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial
Attorney Name: Danielle C. Pfifferling
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial
Attorney Name: Jennifer H. Roscetti
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial - Holding, S.A.
Attorney Name: Steven J. Balick
Ashby & Geddes
Bial - Holding, S.A.
Attorney Name: Meredith H. Boerschlein
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial - Holding, S.A.
Attorney Name: Charles T. Collins-Chase
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial - Holding, S.A.
Attorney Name: Lauren J. Robinson
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial - Holding, S.A.
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Bial - Holding, S.A.
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial - Holding, S.A.
Attorney Name: Danielle C. Pfifferling
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial - Holding, S.A.
Attorney Name: Jennifer H. Roscetti
Finnegan, Henderson, Farabow, Garrett & Dunner
Sunovion Pharmaceuticals
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Sunovion Pharmaceuticals
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell
Sunovion Pharmaceuticals
Attorney Name: Chad Shear
Fish & Richardson
Sunovion Pharmaceuticals
Attorney Name: Jennifer O. Ying
Morris Nichols Arsht & Tunnell
Sunovion Pharmaceuticals
Attorney Name: Megan A. Chacon
Fish & Richardson
Bial - Holding, S.A.
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
BIAL - PORTELA & Cª, S.A.
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Bial - Holding, S.A.
Attorney Name: Constance Pei Hwa Lee
Finnegan, Henderson, Farabow, Garrett & Dunner
BIAL - PORTELA & Cª, S.A.
Attorney Name: Constance Pei Hwa Lee
Finnegan, Henderson, Farabow, Garrett & Dunner
Attorney Name: Erin McGeehan Sommers
Attorney Name: Constance Pei Hwa Lee
Attorney Name: Chad Shear
Defendant Attorneys
12LUOXIN BIOTECHNOLOGY (SHANGHAI) CO., LTD.
Attorney Name: Edward D. Pergament
Pergament & Cepeda LLP
LUOXIN BIOTECHNOLOGY (SHANGHAI) CO., LTD.
Attorney Name: Benjamin J. Schladweiler
Greenberg Traurig LLP
LUOXIN BIOTECHNOLOGY (SHANGHAI) CO., LTD.
Attorney Name: Dmitry V. Shelhoff
Pergament & Cepeda LLP
Sph Shanghai Zhongxi Pharmaceutical Co. Ltd.
Attorney Name: Samuel Lee Moultrie
Greenberg Traurig LLP
Sph Shanghai Zhongxi Pharmaceutical Co. Ltd.
Attorney Name: Edward D. Pergament
Pergament & Cepeda LLP
Sph Shanghai Zhongxi Pharmaceutical Co. Ltd.
Attorney Name: Benjamin J. Schladweiler
Greenberg Traurig LLP
Sph Shanghai Zhongxi Pharmaceutical Co. Ltd.
Attorney Name: Dmitry V. Shelhoff
Pergament & Cepeda LLP
Sph Shanghai Zhongxi Pharmaceutical Co. Ltd.
Attorney Name: Robert J. Scheffel
Dowd Scheffel
Sph Shanghai Zhongxi Pharmaceutical Co. Ltd.
Attorney Name: Matthew James Dowd
Dowd Scheffel
Attorney Name: Eve H. Ormerod
Attorney Name: Matthew James Dowd
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
09763954 | Therapeutical uses of eslicarbazepine | Sep 19, 2017 |
09750747 | Treatments involving eslicarbazepine acetate or eslicarbazepine | Sep 5, 2017 |
09643929 | Asymmetric catalytic reduction of oxcarbazepine | May 9, 2017 |
09566244 | Pharmaceutical composition comprising licarbazepine acetate | Feb 14, 2017 |
09206135 | Asymmetric catalytic reduction of oxcarbazepine | Dec 8, 2015 |
08372431 | Pharmaceutical composition comprising licarbazepine acetate | Feb 12, 2013 |
05753646 | Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them | May 19, 1998 |